This site is intended for healthcare professionals

Welcome to InterACT Podcasts. A series developed by AstraZeneca, where we will be exploring the inequalities of care for people living with long-term conditions.

For more CPD-accredited education, visit

InterACT Medical Education is a series of non-promotional educational resources created and funded by AstraZeneca.

Head of UK External Scientific Engagement

Medical Information Specialist

Are there disparities across the UK in the over-reliance on steroids for patients living with asthma? (Content from AstraZeneca)

In this episode, we focus on the burden of over-reliance on steroids used in the treatment of asthma with Dr Hitasha Rupani, who reflects on her experiences as a Respiratory Consultant based at Southampton Hospitals NHS Trust.

In this episode, we focus on the burden of over-reliance on steroids used in the treatment of asthma with Dr Hitasha Rupani, who reflects on her experiences as a Respiratory Consultant based at Southampton Hospitals NHS Trust.

Dr Hitasha Rupani would like her take-home messages to be:

  • We can do better at the earlier recognition of poorly controlled asthma. This means identifying patients early on in their patient journey, optimising their treatment and referring them to severe asthma centres if required.
  • Realise the importance of empowering patients and providing them with the tools to self-manage their asthma better, by giving them educational information about their condition in a way they want to receive it.
  • Be mindful of the negative impact that over-reliance of oral corticosteroids can have on the patient. They have a place in the acute setting but should not be used long term.

 

Useful links

 

References

In this episode, we focus on the burden of over-reliance on steroids used in the treatment of asthma with Dr Hitasha Rupani, who reflects on her experiences as a Respiratory Consultant based at Southampton Hospitals NHS Trust.

Dr Hitasha Rupani would like her take-home messages to be:

  • We can do better at the earlier recognition of poorly controlled asthma. This means identifying patients early on in their patient journey, optimising their treatment and referring them to severe asthma centres if required.
  • Realise the importance of empowering patients and providing them with the tools to self-manage their asthma better, by giving them educational information about their condition in a way they want to receive it.
  • Be mindful of the negative impact that over-reliance of oral corticosteroids can have on the patient. They have a place in the acute setting but should not be used long term.

 

Useful links

 

References

Adverse events should be reported. Reporting forms and information can be found at
www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by
visiting https://contactazmedical.astrazeneca.com/ or by calling 0800 783 0033.

GB-28289 | DOP May 2021

GPnotebook has had no input into the content of InterACT Podcast episodes.

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.